NIH Gene Therapy Symposium

September 26-27, 2011
Natcher Conference Facility, National Institutes of Health
Bethesda, Maryland, USA

There are several initiatives that have come out of the NIH Gene Therapy Symposium, including:

Communication of outcomes to ASGCT Membership
Letter to Francis Collins detailing the outcomes and next steps for ASGCT, including the identification of the ten target disease most likely to have a validated therapeutic in the next five to seven years
Formulating a panel of ASGCT members to help guide the Office of Rare Disease Research in the grouping of rare diseases into categories of diseases with common clinical phenotypes
Formulating a panel of ASGCT Members to engage in a dialogue with the RAC regarding ways to streamline the current regulatory process for gene therapists

Presentation slides from the NIH Gene Therapy Symposium are now available within the Symposium Program.

Read the recently published article from Science Magazine (October 2011) on the successes of gene and cell therapy: http://www.sciencemag.org/cgi/content/full/334/6052/29?ijkey=Iug/90FfGumDg&keytype=ref&siteid=sci

Last Updated January 11, 2012